Environment to Be 'Better for Banks Period,' Cantor Fitzgerald CEO Lutnick Says

The expected rollback in banking regulation under President-elect Donald Trump is "really good" for banks and means the "pond is definitely getting bigger," Cantor Fitzgerald CEO Howard Lutnick said on CNBC's "Squawk on the Street" on Tuesday morning. 

A prime example of how regulation hurts banks comes from January 2016, when oil fell off the map and the controller of the currency in the Obama administration made it so that money-centered banks couldn't lend to energy companies, Lutnick noted. 

"Can you imagine they just couldn't lend to energy companies because they raised the risk rating and made it so that they had to put so much capital up?" he said. 

Going forward, all of that "nonsense" will go away and banks will be able to take the risk if they have the proper amount of money, Lutnick explained. "So I think it's going to be better business for banks period." 

Despite being a private firm, Cantor Fitzgerald will also benefit from this trend because banks are going to be reexamining who they're doing business with and will turn away smaller firms that aren't "institutionally important" to it, he claimed.  

"Imagine doing business with JPMorgan, (JPM) Morgan Stanley, (MS) Goldman Sachs, (GS) and they say, 'Sorry, you're just not big enough for us.' You need a great firm to do business with," he said.  

That's where his firm can step in, so it doesn't even have to compete with banks. Cantor Fitzgerald is in a "sweet spot in the world going forward," he said.  

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says